» Authors » John E McGowan Jr

John E McGowan Jr

Explore the profile of John E McGowan Jr including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 46
Citations 1868
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
McGowan Jr J
J Antimicrob Chemother . 2016 Aug; 71(9):2370-8. PMID: 27550989
Antimicrobial chemotherapy now spans 80 years and four generations. The healthcare epidemiologist has an important role to play in this field. Efforts focus in three areas: (i) minimizing the transmission...
2.
Stone N, Lewis D, Johnson 2nd T, Hartney T, Chandler D, Byrd-Sellers J, et al.
Infect Control Hosp Epidemiol . 2012 May; 33(6):551-7. PMID: 22561709
Objective: To identify risk factors associated with methicillin-resistant Staphylococcus aureus (MRSA) acquisition in long-term care facility (LTCF) residents. Design: Multicenter, prospective cohort followed over 6 months. Setting: Three Veterans Affairs...
3.
McAllister L, Gaynes R, Rimland D, McGowan Jr J
Infect Control Hosp Epidemiol . 2010 Mar; 31(5):538-40. PMID: 20334507
Our case-control study sought to identify risk factors for colonization with methicillin-resistant Staphylococcus aureus (MRSA) at hospital admission among patients with no known healthcare-related risk factors. We found that patients...
4.
Tenover F, Gay E, Frye S, Eells S, Healy M, McGowan Jr J
J Clin Microbiol . 2009 Jun; 47(8):2452-7. PMID: 19553588
We compared the results of typing methicillin-resistant Staphylococcus aureus (MRSA) isolates using the DiversiLab system (DL) to the results obtained using pulsed-field gel electrophoresis (PFGE). One hundred five MRSA isolates...
5.
Tenover F, Sinner S, Segal R, Huang V, Alexandre S, McGowan Jr J, et al.
Int J Antimicrob Agents . 2009 Feb; 33(6):564-8. PMID: 19233622
Following an initial response to vancomycin therapy, a patient with meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia developed endocarditis, failed a second course of vancomycin and then failed daptomycin therapy. An increase...
6.
Tenover F, Emery S, Spiegel C, Bradford P, Eells S, Endimiani A, et al.
J Clin Microbiol . 2008 Nov; 47(2):294-9. PMID: 19036936
The goal of this study was to determine if the interpretations of extended-spectrum and advanced-spectrum cephalosporins (ESCs and ASCs, respectively) for isolates of Enterobacteriaceae would be impacted by the results...
7.
Graves N, McGowan Jr J
JAMA . 2008 Oct; 300(13):1577-9. PMID: 18827214
No abstract available.
8.
Staras S, Flanders W, Dollard S, Pass R, McGowan Jr J, Cannon M
J Clin Virol . 2008 Sep; 43(3):266-71. PMID: 18778968
Background: Among pre-adolescents, the importance of different sources of cytomegalovirus (CMV) infection is unclear. Objective: To assess the importance of several CMV sources among pre-adolescent children. Study Design: We used...
9.
Kollef M, Morrow L, Baughman R, Craven D, McGowan Jr J, Micek S, et al.
Clin Infect Dis . 2008 Jul; 46 Suppl 4:S296-334. PMID: 18429676
Increasingly, patients are receiving treatment at facilities other than hospitals, including long-term-health care facilities, assisted-living environments, rehabilitation facilities, and dialysis centers. As with hospital environments, nonhospital settings present their own...
10.
DiazGranados C, Cardo D, McGowan Jr J
Int J Antimicrob Agents . 2008 Jun; 32(1):1-9. PMID: 18550343
Microorganisms resistant to multiple anti-infective agents have increased worldwide. These organisms threaten both optimal care of patients with infection as well as the viability of current healthcare systems. In addition,...